USP17L2 and breast cancer: Su et al. reported USP17L2 knowdown-mediated SIRT7 polyubiquitination led to breast cancer cells sensitizing to chemotherapy, which suggests that SIRT7 acts as a procancer protein (Su et al., 2022).